REDWOOD CITY, CA / ACCESSWIRE / November 5, 2024 / Juva Life Inc. (CSE:JUVA)(OTC EXPERT MARKET:JUVAF)(FRANKFURT:4VV) ("Juva" or the "Company"), a life science company with both pharmaceutical research ...

MURFREESBORO, TN / ACCESSWIRE / November 5, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that after more than 30 years of leadership, W. Andrew "Andy" Adams has notified the Board ...

MURFREESBORO, TN / ACCESSWIRE / November 5, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its fourth quarter dividend of $0.90 per common share on January 29, 2025 ...

LEWES, DE / ACCESSWIRE / November 5, 2024 / Beebe Healthcare has partnered with Sublimation Health to transform its digital landscape with an Epic Electronic Health Record (EHR) system hosted on ...

Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized neoantigen cancer immunotherapies, announces further promising data from the fully enrolled Phase 1b/2 study ...

CALGARY, AB / ACCESSWIRE / November 5, 2024 / CannaPharmaRX, Inc. (OTC PINK:CPMD), a future leader in cutting-edge, highly efficient cannabis production, is pleased to announce continued progress at ...

Predicated on an unrivaled trove of millions of data points amassed over 20 years, these AI tools accurately predict near-term risk of ED, all-cause hospitalization, or death sans mitigation.NEW YORK, ...

Tessellate BIO, a preclinical stage biotechnology company with a focus on novel Synthetic Lethality approaches, today announces the appointment of Dr. Lara Boyd as Chief Business Officer.

PersonnelPharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as Chief Executive Officer 05-Nov-2024 / 10:02 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the ...

Nxera Pharma (“Nxera”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – and Antiverse, a techbio company designing antibodies for challenging targets, have today announced a multi-target ...

WebHealthAI is seeing explosive growth, gaining over 3 million users in the past 30 days—a staggering 4,566% increase in monthly users since its launch less than a year ago. This platform ...

Brings over 30 years of experience in cardiovascular clinical research, business development, training, education, and medical affairs Strengthens Xeltis’ leadership team following IDE approval for ...